Cargando…
Targeting Hedgehog (Hh) Pathway for the Acute Myeloid Leukemia Treatment
The Hedgehog (Hh) pathway, containing the Patched (PTCH) and Smoothened (SMO) multitransmembrane proteins, is the main regulator of vertebrate embryonic development. A non-canonical Hh pathway was recently observed in numerous types of solid cancers and hematological malignancies. Although acute mye...
Autores principales: | Terao, Toshiki, Minami, Yosuke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6523210/ https://www.ncbi.nlm.nih.gov/pubmed/30987263 http://dx.doi.org/10.3390/cells8040312 |
Ejemplares similares
-
The Hedgehog Pathway as a Therapeutic Target in Chronic Myeloid Leukemia
por: Wu, Andrew, et al.
Publicado: (2023) -
NANOG Expression as a Responsive Biomarker during Treatment with Hedgehog Signal Inhibitor in Acute Myeloid Leukemia
por: Kakiuchi, Seiji, et al.
Publicado: (2017) -
Small‐molecule Hedgehog inhibitor attenuates the leukemia‐initiation potential of acute myeloid leukemia cells
por: Fukushima, Nobuaki, et al.
Publicado: (2016) -
Emerging Targeted Therapy for Specific Genomic Abnormalities in Acute Myeloid Leukemia
por: Chi, Sung-Gi, et al.
Publicado: (2022) -
Acute myeloid leukemia – strategies and challenges for targeting oncogenic Hedgehog/GLI signaling
por: Aberger, Fritz, et al.
Publicado: (2017)